Trial Profile
Effects of Ranolazine on Myocardial Perfusion in Patients With Dilated Cardiomyopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Dilated cardiomyopathy
- Focus Therapeutic Use
- Acronyms RAMP-DCM
- 27 Apr 2021 Status changed from recruiting to completed.
- 09 Jul 2014 New trial record